Corsee Sanders, Ph.D., joined our Board of Directors in 2020.

Most recently, Dr. Sanders served as Strategic Advisor to the Office of the Celgene Chief Medical Officer and Transition Advisor to Bristol Myers Squibb. Prior to that, she was a member of the executive committee at Juno Therapeutics and served as Executive Vice President of Development Operations. Dr. Sanders previously held several senior leadership positions at Genentech/Roche, including Global Head of Biometrics and Global Head of Clinical Operations. She additionally was Co-Chair of the Roche-Chugai Joint Portfolio Management Committee. Dr. Sanders currently serves on the Board of Trustees for the Fred Hutchinson Cancer Research Center and on the board of directors of Molecular Templates Inc., Legend Biotech Corporation, and AltruBio (formerly AbGenomics) Inc.

Dr. Sanders holds a B.S. and M.S. in statistics from the University of the Philippines, as well as an M.A. and a Ph.D. in statistics from the Wharton Doctoral Program at the University of Pennsylvania.